Kristin Brachwitz
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, CAR-T cell therapy research, Protein Degradation and Inhibitors, Lymphoma Diagnosis and Treatment, Synthesis and biological activity
Most-Cited Works
- → Microarray analysis of Ewing’s sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy(2008)96 cited
- → Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including ERBB3 (2004)74 cited
- → Constitutive Activation of Neuregulin/ERBB3 Signaling Pathway in Clear Cell Sarcoma of Soft Tissue(2006)29 cited
- → Evaluation of the First Cytostatically Active 1-Aza-9-oxafluorenes as Novel Selective CDK1 Inhibitors with P-Glycoprotein Modulating Properties(2003)27 cited
- → Synthesis and first biological evaluation of 1-aza-9-oxafluorenes as novel lead structures for the development of small-sized cytostatics(2002)16 cited
- → Regioselective Formation of Novel Functionalized 1-Aza-9-oxafluorenes(2001)14 cited
- → Supplementary Table 2 from Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including <b><i>ERBB3</i></b>(2023)
- → Data from Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including <b><i>ERBB3</i></b>(2023)
- → Supplementary Table 1 from Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including <b><i>ERBB3</i></b>(2023)